169 related articles for article (PubMed ID: 8393153)
1. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors.
Wieland S; Fischette CT; Lucki I
Neuropharmacology; 1993 Jun; 32(6):561-73. PubMed ID: 8393153
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M
J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718
[TBL] [Abstract][Full Text] [Related]
3. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
Godbout R; Chaput Y; Blier P; de Montigny C
Neuropharmacology; 1991 Jul; 30(7):679-90. PubMed ID: 1681446
[TBL] [Abstract][Full Text] [Related]
4. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with tandospirone, a 5-HT(1A) receptor partial agonist, suppresses footshock stress-induced lactate production in the prefrontal cortex of rats.
Uehara T; Matsuoka T; Itoh H; Sumiyoshi T
Pharmacol Biochem Behav; 2013 Nov; 113():1-6. PubMed ID: 24125783
[TBL] [Abstract][Full Text] [Related]
6. Changes in serotonergic measures in whole blood and various brain regions of rats administered with the 5-HT1A agonist tandospirone and/or exposed to electric foot-shock.
Takada Y; Urano T; Malyszko J; Takada A
Brain Res Bull; 1996; 40(1):51-5. PubMed ID: 8722753
[TBL] [Abstract][Full Text] [Related]
7. Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo.
Sullivan NR; Crane JW; Damjanoska KJ; Carrasco GA; D'Souza DN; Garcia F; Van de Kar LD
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):18-26. PubMed ID: 15655673
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism.
Mendelson SD; Quartermain D; Francisco T; Shemer A
Eur J Pharmacol; 1993 May; 236(2):177-82. PubMed ID: 8319749
[TBL] [Abstract][Full Text] [Related]
9. Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain.
Tanaka H; Tatsuno T; Shimizu H; Hirose A; Kumasaka Y; Nakamura M
Gen Pharmacol; 1995 Dec; 26(8):1765-72. PubMed ID: 8745167
[TBL] [Abstract][Full Text] [Related]
10. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
Blier P; Curet O; Chaput Y; de Montigny C
Neuropharmacology; 1991 Jul; 30(7):691-701. PubMed ID: 1681447
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test.
Shimizu H; Tatsuno T; Tanaka H; Hirose A; Araki Y; Nakamura M
Jpn J Pharmacol; 1992 May; 59(1):105-12. PubMed ID: 1354771
[TBL] [Abstract][Full Text] [Related]
12. Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats.
Bubenikova-Valesova V; Svoboda J; Horacek J; Sumiyoshi T
Psychopharmacology (Berl); 2010 Oct; 212(2):267-76. PubMed ID: 20676611
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites.
Hamik A; Oksenberg D; Fischette C; Peroutka SJ
Biol Psychiatry; 1990 Jul; 28(2):99-109. PubMed ID: 1974152
[TBL] [Abstract][Full Text] [Related]
14. In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
Nakayama T; Suhara T; Okubo Y; Ichimiya T; Yasuno F; Maeda J; Takano A; Saijo T; Suzuki K
Psychopharmacology (Berl); 2002 Dec; 165(1):37-42. PubMed ID: 12474116
[TBL] [Abstract][Full Text] [Related]
15. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
Matsubara K; Shimizu K; Suno M; Ogawa K; Awaya T; Yamada T; Noda T; Satomi M; Ohtaki K; Chiba K; Tasaki Y; Shiono H
Brain Res; 2006 Sep; 1112(1):126-33. PubMed ID: 16884702
[TBL] [Abstract][Full Text] [Related]
16. Tandospirone, a Partial 5-HT1A Receptor Agonist, Administered Systemically or Into Anterior Cingulate Attenuates Repetitive Behaviors in Shank3B Mice.
Dunn JT; Mroczek J; Patel HR; Ragozzino ME
Int J Neuropsychopharmacol; 2020 Nov; 23(8):533-542. PubMed ID: 32619232
[TBL] [Abstract][Full Text] [Related]
17. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.
Maj J; Bijak M; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G; Tokarski T
Psychopharmacology (Berl); 1996 Sep; 127(1):73-82. PubMed ID: 8880946
[TBL] [Abstract][Full Text] [Related]
18. Effects of SUN 8399, a potent and selective 5-HT1A agonist, on conflict behavior and ambulatory activity in mice: comparison with those of buspirone, tandospirone and diazepam.
Kuribara H
Jpn J Pharmacol; 1994 Apr; 64(4):273-80. PubMed ID: 8057528
[TBL] [Abstract][Full Text] [Related]
19. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor.
Ohmura Y; Kumamoto H; Tsutsui-Kimura I; Minami M; Izumi T; Yoshida T; Yoshioka M
J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971
[TBL] [Abstract][Full Text] [Related]
20. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
